葛兰素史克诉梯瓦:联邦巡回法院扩大诱导侵权以排除非专利适应症的仿制药销售

{"title":"葛兰素史克诉梯瓦:联邦巡回法院扩大诱导侵权以排除非专利适应症的仿制药销售","authors":"Paul A. Braier","doi":"10.1177/1741134321999698","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":15914,"journal":{"name":"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector","volume":"20 1","pages":"97 - 101"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GlaxoSmithKline v. Teva: Federal circuit broadens induced infringement to preclude marketing generics for off-patent indications\",\"authors\":\"Paul A. Braier\",\"doi\":\"10.1177/1741134321999698\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":15914,\"journal\":{\"name\":\"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector\",\"volume\":\"20 1\",\"pages\":\"97 - 101\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1741134321999698\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1741134321999698","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}